- NGS panel for the study of the the following oncohematological diseases: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), myeloproliferative neoplasms (MPN), acute lymphoid leukemia (ALL), and myelodysplastic syndromes.
- Detects SNVs, indels, genetic fusions, CNVs, and pharmacogenetic variants in a single DNA sample.
- Bioinformatics analysis with the Datagenomics software and semiautomated generation of reports, including functional and clinical classification of the identified variants.
- STIDs can be included: Integrated sample identification and tracking system.
- Based on high sensitivity RNA-probe technology with UMI barcoding (unique molecular identifiers).
- Coverage (at depth >1000x), specificity, sensitivity, repeatability, and reproducibility of this test are over 99%. The uniformity of bases covered at >20x
Description
Analysis of the main molecular markers related to ALL, AML, CML, MDS, MPN and other hematological neoplasms, by means of NGS sequencing. For in vitro diagnostic use. CE marking.
Format
24 rxn
Technology
NGS sequencing
Reference
IMG-363
Compatible equipment
Illumina sequencing platforms
Haematology OncoKitDx employs fully automated library preparation technology by mechanical fragmentation and enrichment of regions of interest by hybridization with capture probes. Subsequently, massive sequencing is carried out on Illumina platforms.
| Compatible sequencers: | Illumina NextSeq 500/550/550Dx. |
| Number of reactions: | 24 |
| Number of samples per run: | 8 samples in a cartridge MID 150 cycles on NextSeq. |
| Sequencing: | Paired-end (2 x 75 cycles). |
| Type of sample: | 50-100 ng. |
| Amount of input DNA: | 802 Kb |
| Limit of detection: | SNVs and Indels: 2%, CNVs: 20%, and copy losses or gains: 10% |
| Fully automated panel for Magnis NGS Prep System Dx equipment. | |
| CE-IVD-marked kit and analysis software. | |
| Genes diana | SNVs e INDELs: ARID5B, ASXL1, ASXL2, ATRX, BCOR, BCORL1, BLNK, BRAF, CALR, CBL, CDKN2A, CDKN2B, CEBPA, CHIC2, CREBBP, CRLF2, CSF3R, CSNK1A1, CUX1, DDX3X, DDX41, DNMT3A, EP300, ETNK1, ETV6, EZH2, FBXW7, FLT3, GATA1, GATA2 (e intrón 4), GATA3, HAVCR2, IDH1, IDH2, IKZF1, IL7R, JAK1, JAK2, JAK3, KIT, KMT2A, KMT2C, KRAS, MPL, NF1, NFE2, NOTCH1, NPM1, NR3C1, NRAS, P2RY8, PAX5, PHF6, PIGA, PPM1D, PTEN, PTK2B, PTPN11, RAD21, RB1, RUNX1, SETBP1, SF3B1, SH2B3, SMC1A, SMC3, SRP72, SRSF2, STAG1, STAG2, STAT5B, TET2, TP53, TYK2, U2AF1, WT1, ZRSR2.
SVs: ABL1 (región 5’UTR, intrones 1, 2 y 3), ABL2 (intrones 3, 4 y 5), BCR (intrones 6, 13, 14, 15 y 19), CBFA2T3 (intrones 10 y 11 y región 3’UTR), CBFB (intrón 5), CSF1R (intrón 11 y 13), EPOR (intrón 7 y CDS exón 8), ETV6 (intrones 2, 3, 4 y 5), FGFR1 (intrones 7, 8, 9 y 10), FUS (intrones 5, 6, 7, 8, 9, 11 y 14), JAK2 (intrones 8, 9, 10, 11, 15, 16, 17, 18 y 19), KMT2A (intrones 6, 7, 8, 9, 10, 11, 15, 22 y 29), MEF2D (intrones 5 y 6), MNX1 (intrones 1 y 2), MYH11 (intrón 7), NPM1 (intrón 4), NUP214 (intrones 1, 9, 16 y 17), NUP98 (intrones 10, 11, 12, 13 y 14), PDGFRA (intrones 11 y 12), PDGFRB (intrones 9, 10, 11 y 12), RARA (intrón 2), RBM15 (intrón 1), RUNX1 (intrón 6), SET (intrón 7), STIL (región 5’UTR), TAL1 (intrón 3) y TCF3 (intrones 13, 14, 15, 16 y 17). |
| Tipo de muestra | ADN procedente de sangre periférica y médula ósea |
Related kits
Haematology OncoKitDx
Fill in the form to request this kit.
Call us at +34 963 212 340Or write to us at info@healthincode.com
